These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1580656)

  • 1. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
    Yamada K; Walsh N; Hara H; Jimbow K; Chen H; Ito S
    Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanin-related metabolites in urine of B16 melanoma-bearing mice.
    Wakamatsu K; Ito S; Fujita K
    Acta Derm Venereol; 1988; 68(5):385-9. PubMed ID: 2461020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some indolic compounds as markers of the melanocyte activity.
    Hansson C
    Acta Derm Venereol Suppl (Stockh); 1988; 138():1-60. PubMed ID: 3176811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma.
    Kärnell R; von Schoultz E; Hansson LO; Nilsson B; Arstrand K; Kågedal B
    Melanoma Res; 1997 Oct; 7(5):393-9. PubMed ID: 9429222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between urinary melanin-related metabolites and tumour weight in melanoma-bearing mice.
    Ito S; Wakamatsu K; Inoue S; Fujita K
    Acta Derm Venereol; 1989; 69(5):380-4. PubMed ID: 2572100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-S-cysteinyldopa in the urine of melanoma patients.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
    Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichochromuria in melanosis of melanoma.
    Rorsman H; Agrup P; Carlén B; Hansson C; Jonsson N; Rosengren E; Tegner E
    Acta Derm Venereol; 1986; 66(6):468-73. PubMed ID: 2433864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal values of urinary excretion and serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid, biochemical markers of melanoma progression.
    Wakamatsu K; Ito S; Horikoshi T
    Melanoma Res; 1991; 1(2):141-7. PubMed ID: 1823626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of melanocytic metabolites in fertile women.
    Carstam R; Hansson C; Rorsman H; Rosengren E; Sjöberg NO; Wirestrand LE
    Acta Derm Venereol; 1985; 65(6):543-5. PubMed ID: 2420122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Eumelanin and pheomelanin contents in hairs of healthy Japanese and patients with oculocutaneous albinism, and 5-S-cysteinyldopa and 5-hydroxy-6-methoxyindole-2-carboxylic acid levels in urine of oculocutaneous albinism].
    Saito N; Morishima T
    Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):853-61. PubMed ID: 2122048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of 6-hydroxy-5-methoxyindole-2-carboxylic acid and 5-S-cysteinyldopa during PUVA treatment.
    Hansson C; Wirestrand LE; Aronsson A; Rorsman H; Rosengren E
    Photodermatol; 1985 Apr; 2(2):52-7. PubMed ID: 3929237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
    Agrup G; Agrup P; Andersson T; Hafström L; Hansson C; Jacobsson S; Jönsson PE; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(5):381-8. PubMed ID: 93360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
    Paul E; Graef V; Ruppel R; Hellwich M
    Z Hautkr; 1983 Feb; 58(4):262-5. PubMed ID: 6405551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies between excretion of 5-S-cysteinyldopa and indole melanogens in urine].
    Beyer C; Fiedler H; Wohlrab W; Wozniak KD
    Dermatol Monatsschr; 1986; 172(9):541-4. PubMed ID: 3098590
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson J-A ; Jacobsson S; Rorsman H; Rosengrem A-M ; Rosengren E
    Acta Derm Venereol; 1975; 55(5):337-41. PubMed ID: 52967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid: differences between pigmented and albino mice.
    Ekelund MC; Carstam R; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1985; 65(5):437-9. PubMed ID: 2416171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy.
    Wimmer I; Meyer JC; Seifert B; Dummer R; Flace A; Burg G
    Cancer Res; 1997 Nov; 57(22):5073-6. PubMed ID: 9371505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations].
    Paul E; Graef V; Ruppel R
    Z Hautkr; 1980 Dec; 55(23):1543-60. PubMed ID: 6782780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stability of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in human urine.
    Kågedal B; Lenner L; Arstrand K; Hansson C
    Pigment Cell Res; 1992; Suppl 2():304-7. PubMed ID: 1409435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of cysteinyldopa in the follow-up of disseminated malignant melanoma.
    Kärnell R; Kågedal B; Lindholm C; Nilsson B; Arstrand K; Ringborg U
    Melanoma Res; 2000 Aug; 10(4):363-9. PubMed ID: 10985671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.